Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-003446

Director bought 8,845 shares at an average $0.71 ($6,275)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-09 Purchase : show line 1 in the form +2,792 $0.73 $2,038 98,629 D
2019-01-10 Purchase : show line 2 in the form +6,053 $0.70 $4,237 104,682 D
Open-market purchases · 8,845 sh · avg $0.71 · $6,275
Loading xslF345X03/doc4.xml…